Inflammatory bowel disease as a risk factor for colorectal cancer

Digestive Diseases

Volumn 28, Issue 4-5, 2010, Pages 619-624

  Lukas, Milan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Colorectal cancer; Crohn's disease; Dysplasia; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; URSODEOXYCHOLIC ACID;

CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; CHEMOPROPHYLAXIS; CHROMOENDOSCOPY; CLINICAL TRIAL; COLON POLYP; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CONFERENCE PAPER; DISEASE COURSE; DISEASE SURVEILLANCE; DYSPLASIA; ENTERITIS; HIGH GRADE DYSPLASIA; HISTOLOGY; HUMAN; META ANALYSIS; PATHOGENESIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROCTITIS; SYSTEMATIC REVIEW;

CHEMOPREVENTION; COLORECTAL NEOPLASMS; ENDOSCOPY; HUMANS; INFLAMMATORY BOWEL DISEASES; RISK FACTORS;

EID: 78649368287     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320276     Document Type: Conference Paper

References (36)

1. Crohn B, Rosenberg H: The sigmoidoscopic picture of chronic ulcerative colitis (nonspecific). Am J Med Sci 1925; 170:220-227.
2. Gillen CD, Andrews HA, Prior P, Allan RN: Crohn's disease and colorectal cancer. Gut 1994; 35: 651-655.
3. Ouaïssi M, Maggiori L, Alves A, et al: Colorectal cancer complicating IBD: a comparative study in CD vs UC in 34 patients. Colorect a l Dis DOI: 10.1111/j.1463-1318. 2010.02241.
4. Eaden JA, Abrams KR, Mayberry JF: The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-535.
5. Bernstein CN, Blanchard JF, Kliewer E, Waj-da A: Cancer risk in patients w ith inf lamma-tory bowel disease: a population based study. Ca ncer 20 01; 91 : 854-862.
6. Rutter MD, Saunders BP, Wilkinson KH, et al: Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcer-ative colitis. Gastroenterology 2006; 130: 1030-1038.
7. Lakatos L, Mester G, Erdelyi Z, et al: Risk factors for ulcerative colitis-associated co-lorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis 2006; 12:205-211.
8. Ahmadi A, Polyak S, Draganov PV: Colo-rectal cancer surveillance in inflammatory bowel disease: the search continues. World J Gastroenterol 2009; 15:61-66.
9. Jess T, Loftus EV Jr, Velayos FS, et al: Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olm-sted County, Minnesota. Gastroenterology 2006; 130 : 1039-1046.
10. Gillen CD, Walmsley RS, Prior P, et al: Ulcer-ative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994; 35 : 1590 -159 2.
11. Greenstein AJ, Sachar DB, Smith H, et al: Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroen-terology 1979; 77:290-294.
12. Askling J, Dickman PW, Karlén P, et al: Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastro-enterology 2001; 120:1356-1362.
13. Ekbom A, Helmick C, Zack M, Adami HO: Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323:1228-1233.
14. Pinczowski D, Ekbom A, Baron J, et al: Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gas-troenterology 1994; 107:117-120.
15. Claessen MM, Lutgens MW, van Buuren HR: More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis. Inflamm Bowel Dis 2009; 15: 1331-1336.
16. Rutter M, Saunders B, Wilkinson K, et al. : Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126:451-459.
17. Delaunoit T, Limburg PJ, Goldberg RM, et al: Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gas-troenterol Hepatol 2006; 4:335-342.
18. Soderlund S, Brandt L, Lapidus A, et al: Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastronterology 2009; 136: 1561-1567.
19. Xie J, Itzkowitz SH: Cancer in inflammatory bowel disease. World J Gastroenterol 2008; 21;14 : 378-389.
20. Herszeny i l, Miheller P, Tulassay Z: Carcino-genesis in inflammatory bowel disease. Dig Dis 2007; 25: 267-269.
21. Blackstone MO, Riddell RH, Rogers BH, Levin B: Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in longstanding ulcerative colitis: an indication for colectomy. Gastroenterology 1981; 80:366-374.
22. Potack J, Itzkowitz SH: Colorectal cancer in inflammatory bowel disease. Gut Liver 2008; 2:61-73.
23. Rubin PH, Friedman S, Harpaz N, et al: Colonoscopic polypectomy in chronic colitis: conservative management after endo-scopic resection of dysplastic polyps. Gastro-enterology 1999; 117:1295-1300.
24. Ullman TA, Croog T, Harpaz N, Sachar D, Itzkowitz S: Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003; 125: 1311-1319.
25. Itzkowitz SH, Present DH: Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 314-321.
26. Stange EF, Travis SP, Vermeire S, et al: European consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohn's Colitis 2008; 2: 1-23.
27. Karlen P, Kornfeld D, Brostrom O, et al: Is colonoscopic surveillance reducing colorec-tal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998; 42: 711-714.
28. Kiesslich R, Frisch J, Holtman M, et al: Meth-ylene blue aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenter-ology 2003; 124: 880-888.
29. Hurlstone DP, Sanders DS, Lobo AJ, et al: Indigo carmine assisted high magnification chromoscopic colonoscopy for the detection and characterization of intraepithelial neo-plasia and colon cancer in ulcerative colitis: a prospective evaluation. Endoscopy 2005; 37: 1186-1192.
30. Cheon JH, Kim WH: Recent advances of en-doscopy in inflammatory bowel diseases. Gut Liver 2007; 1:118-125.
31. Dekker E, van den Broek FJ, Reitsma JB, et al: Narrow band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ul-cerative colitis. Endoscopy 2007; 39:216-221.
32. Velayos FS, Terdiman JP, Walsh JM: Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol 2005; 100:1345-1353.
33. Andrews JM, Travis SPL, Gibson PR, Gasche C: Systematic review: does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes? Aliment Pharmacol Ther 2009; 29: 459-469.
34. Tung BY, Emond MJ, Haggitt RC, et al: Ur-sodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001; 134: 89-95.
35. Pardi DS, Loftus EV Jr, Kremers WK, et al: Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenter-ology 2003; 124:889-893.
36. van Staa TP, Card T, Logan RF, Leufkens HG: 5-Aminosalicylate use and colorectal ca ncer risk i n inflammatory bowel d isea se: a large epidemiological study. Gut 2005;54: 1573-1578.